Endotoxin fears prompt FDA recall of eye product
This article was originally published in Clinica
The US FDA has asked a Massachusetts manufacturer to recall all brands of a saline solution used to irrigate eyes during cataract surgery after receiving more than 300 reports of injuries. The product, Balanced Salt Solution, made by privately-held Cytosol Laboratories, of Braintree, contains dangerous levels of endotoxin, a bacterial by-product, the FDA said.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.